Libo Pharma Corp. (7888)
Market Closed
13 Aug, 05:30
TWSE TWSE Primary NT$
29. 90
+0.4
+1.3559%
NT$
- Market Cap
- P/E Ratio
- Div Yield
7,050 Volume
- Eps
NT$ 29.5
Previous Close Want to track 7888 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Libo Pharma Corp. (7888) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.31B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 1.99
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.56
Overview
Shares outstanding -
Float 41.95M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 23.61K
Average volume (90 days) 34.72K
Price summary
52-Week low 27.5
52-Week high 69
Beta -
50-Day moving average 33.86
200-Day moving average 42.22
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.25%
Return on equity -0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -286.65M
Net income to common (ttm) -296.3M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 801.03M
Total cash per share (mrq) 10.65
Total debt (mrq) 1.32M
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 43.19%
Book value per share (mrq) 14.1
Cash Flow
Cash flow statement -349.1M
Levered free cash flow (LFCF) -246.01M
